Patents
Patents for C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
01/2011
01/27/2011WO2011009203A1 Methods of making efavirenz and intermediates thereof
01/27/2011US20110021529 P53 activating compounds
01/27/2011US20110021520 Oxazine derivatives and their use in the treatment of neurological disorders
01/27/2011US20110021514 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same
01/27/2011US20110021450 Medicinal composition containing benzo[a]phenoxazine compound as the active ingredient for prevention or treatment of protozoal disease
01/27/2011CA2768980A1 Oxazine derivatives and their use as bace inhibitors for the treatment of neurological disorders
01/27/2011CA2768712A1 Methods of making efavirenz and intermediates thereof
01/26/2011CN101959870A Preparation of morpholine derivatives
01/26/2011CN101959427A Flavor molecules
01/25/2011US7875722 Method for producing quinolone carboxylic acid derivative
01/25/2011US7875611 Ion channel modulating compounds and uses thereof
01/25/2011US7875261 Staining; for detecting reactive oxygen species such as hydrogen peroxide; used in immunology, diagnostics, molecular biology and fluorescence based assays
01/20/2011WO2011007367A1 An improved process for preparation of efavirenz
01/20/2011US20110015392 Process for preparing pyridone derivatives 226
01/20/2011US20110015314 Ultraviolet absorbent and production method of the same
01/20/2011US20110015189 Methods of making efavirenz and intermediates thereof
01/20/2011US20110015157 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
01/19/2011CN101952262A Halogen-free benzoxazine based curable compositions for high TG applications
01/19/2011CN101948464A 3,4,6-triaryl-(1,3)-oxazine-2-ketone compound as well as preparation method and application thereof
01/18/2011US7872125 1-Methyl,3-((1,3-dichloro-phenyl)-carbonylamino-(1-carboxy- eth-1,2-ylene)-(1,4-phenylene)-)quinazolin-2,4-dione; inhibiting the adhesion of VCAM-1 (vascular cellular adhesion molecules-1) to alpha-4 integrin; antiinflammatory agents; cardiovascular disorders; multiple sclerosis; antiarthritic agent
01/18/2011US7872123 Process of making α-aminooxyketone/α-aminooxyaldehyde and α-hydroxyketone/α-hydroxyaldehyde compounds and a process making reaction products from cyclic α,β-unsaturated ketone substrates and nitroso substrates
01/18/2011US7872007 reacting N-hydroxymorpholine with 2-cyclohexen-1-one, in the presence of an oxidizer, to obtaining an isoxazolidine chemical intermediate, then converting isoxazolidine intermediate into 2-(4-hydroxy-3-morpholinyl)-2-cyclohexenone
01/13/2011US20110009629 Preparation of morpholine derivatives
01/13/2011US20110009627 Reactor for carrying out high pressure reactions, method for starting and method for carrying out a reaction
01/13/2011US20110009622 Long-chain fatty acyl elongase inhibitor comprising arylsulfonyl derivative as active ingredient
01/13/2011US20110009617 Ruthenium Catalysts and Uses Thereof
01/13/2011US20110009536 C.i. pigment violet 37 in rod-like form
01/13/2011US20110008461 Inhibitor scaffold for the inhibition of the enzyme phosphoenolpyruvate carboxykinase
01/12/2011EP2272821A2 Trinuclear phenolic compounds
01/12/2011EP1797062B1 Alkynyl based dervatives of benzophenone as non-nucleoside reverse transcriptase inhibitors
01/12/2011CN101941920A Aromatic ketone oxime photoinitiator compound
01/12/2011CN101941917A Amide compounds and use thereof
01/11/2011US7868204 Inhibitors of histone deacetylase
01/11/2011US7867949 Hydrazide compound and pesticidal use of the same
01/06/2011WO2011002910A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
01/06/2011WO2009116081A3 An improved process for the preparation of aprepitant
01/06/2011US20110004951 Methods and compositions for identifying compounds that inhibit hiv-1 subunit-specific reverse transcriptase
01/06/2011US20110003795 Substituted Aromatic Carboxamide and Urea Derivatives as Vanilloid Receptor Ligands
01/05/2011EP2270006A1 Pyridazine derivatives useful as vanilloid receptor ligands
01/05/2011EP2269996A1 Medicinal composition containing benzo[a]phenoxanthin compound as the active ingredient for preventing or treating protozoal disease
01/05/2011EP2268616A1 Substituted pyrrolidine and piperidine compounds, derivatives thereof, and methods for treating pain
01/05/2011EP1542692B1 Aminopyrimidine derivatives for use as vanilloid receptor ligands for the treatment of pain
01/05/2011CN101939298A Process for preparing pyridone derivatives
01/04/2011CA2488363C O-substituted hydroxyaryl derivatives
12/2010
12/30/2010US20100331329 Benzamide derivatives useful as histone deacetylase inhibitors
12/30/2010US20100331321 Bis-(Sulfonylamino) derivatives for use in therapy
12/30/2010US20100331288 Crystalline hydrate of betamimetika and use as medicament thereof
12/30/2010US20100327735 Fluorene dimers and trimers
12/29/2010CN101928257A Isatoic acid anhydride synthesis method
12/29/2010CN101928256A 3-alkyl-2-aryl-1,3-benzoxazine with bactericidal activity
12/29/2010CN101525318B Method for preparing 2, 6-dimethyl-N-tridecyl drewamine
12/29/2010CA2764956A1 Novel biphenyl and phenyl-pyridine amides
12/28/2010US7858617 2-hexadecyloxy-6-methyl-4H-3,1-benzoxazin-4-one; inhibition of a lipase, esterase or phosphatase enzyme
12/23/2010WO2010148397A1 Bait chemistries in hydrogel particles for serum biomarker analysis
12/23/2010WO2010145992A1 Herbicidal benzoxazinones
12/23/2010US20100324285 Antiinflammatory agent comprising 2-aminophenol or derivative thereof as active ingredient
12/23/2010US20100324046 4-carboxybenzylamino derivatives as histone deacetylase inhibitors
12/23/2010US20100323396 Platelet measurement reagent, platelet measurement reagent kit, and platelet measurement method
12/23/2010CA2763938A1 Herbicidal benzoxazinones
12/22/2010EP2264037A1 Vasopressin v1a antagonists
12/22/2010CN101921266A 3,4,6-triaryl-[1,3]-oxazine compound as well as preparation method and application thereof
12/22/2010CN101921242A Fluorenyl benzoxazine and preparation method thereof
12/21/2010US7855199 antitumor agents such as 2-(2-difluoromethyl-4-methoxybenzimidazol-1 -yl)-4-(cis-2,6-dimethylmorpholino)-6-morpholinopyrimidine, used for inhibiting the growth of a human colon cancer cell, a human lung cancer cell, a human breast cancer cell or a human prostate cancer cell
12/21/2010US7855198 Benzamide derivative or salt thereof
12/16/2010WO2010142650A1 Novel cyclopentane derivatives
12/16/2010US20100317647 Novel cyclopentane derivatives
12/16/2010CA2762619A1 Novel cyclopentane derivatives
12/15/2010EP2260029A1 Preparation of morpholine derivatives
12/15/2010EP2259689A1 Flavor molecules
12/15/2010CN1909909B 1-benzyl-5-piperazin-1-yl-3,4-dihydro-1H- quinazolin-2-one derivatives and the respective 1H-benzo(1,2,6)thiadiazine-2,2-dioxide and 1,4-dihydro-benzene as modulators of the 5-hydroxytryptamine recept
12/15/2010CN1708480B Carotenoid analogs for the inhibition and amelioration of disease
12/14/2010CA2437944C Acylated indanyl amines and their use as pharmaceuticals
12/09/2010WO2010139758A1 Novel derivatives of aryl-{4-halogeno-4-[aminomethyl]-piperidin-1-yl}-methanone, their method of preparation and their use as medicinal products
12/09/2010WO2010139673A1 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
12/09/2010US20100311967 Production of bepromoline
12/08/2010EP2258692A1 Thiol detection method
12/08/2010CN1950380B (1,10b-dihydro-2-(aminocarbonyl-phenyl)-5h-pyrazolo[1,5- c][1,3]benzoxazin-5-yl)phenyl methanone derivatives as HIV viral replication inhibitors
12/08/2010CN101910183A Process for production of 4-(substituted phenyl)hexahydropyrido[2,1-c][1,4]oxazin-6-one
12/07/2010US7847095 Process for 5-[[2(r)-[1(r)-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3(s)-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3h-1.,2,4-triazol-3-one
12/07/2010US7846925 such as 5-(1,3-benzodioxol-5-ylmethylene)-1,3-thiazolidine-2,4-dione, used for the treatment and/or prophylaxis of autoimmune, cardiovascular or neurodegenerative disorders, inflammatory or kidney diseases, bacterial or viral infections, platelet aggregation, cancer, transplant rejection or lung injuries
12/07/2010CA2668294C Method of making ketals and acetals
12/02/2010WO2010136037A1 Novel calcium sensing receptor modulating compounds and pharmaceutical use thereof
12/02/2010US20100305129 Compositions and methods for inhibiting growth and metastasis of melanoma
12/02/2010US20100305116 Compounds Comprising a Cyclobutoxy Group
12/02/2010US20100305072 Substituted Tetracycline Compounds
12/02/2010US20100304966 Fungicidal Compounds, Method For the Production Thereof, And Use Thereof To Combat Damaging Fungi, And Agents Comprising The Same
12/02/2010CA2762137A1 Novel calcium sensing receptor modulating compounds and pharmaceutical use thereof
12/01/2010EP2256119A1 Vasopressin V1a antagonists
12/01/2010EP2254875A2 Halogen-free benzoxazine based curable compositions for high tg applications
12/01/2010EP2254872A2 Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
12/01/2010CN101898982A Npy y5 antagonists
11/2010
11/30/2010US7842814 deprotecting, aldol condensations, cleaving double bonds, deesterifying, alcoholization, oxidation with organometallic, lactonization
11/30/2010US7842804 Ionic salts comprising pyrrolidinium, triazolinium, piperidinium or morpholinium cations and alkyltrifluorophosphate anions
11/30/2010US7842803 Nicotinic acetylcholine receptor ligands 101
11/30/2010US7842690 Cyclic hydroxylamine as psychoactive compounds
11/30/2010US7842689 Cyclic hydroxylamine as psychoactive compounds
11/30/2010CA2519938C Prostaglandin analogs as ep4 receptor agonists
11/30/2010CA2335477C Sulfonamide inhibitors of aspartyl protease
11/25/2010WO2010133180A1 Poly-iodo benzene compound, preparation method and use thereof
11/25/2010US20100298329 Tolperisone and tolperisone-like drugs for the treatment of k-ras associated cancers
1 ... 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 ... 112